AI-Driven Personalization in Digital Marketing: Algorithmic Approaches and Applications in the Life Sciences Industry

<i>This paper examines how artificial intelligence (AI) is transforming digital marketing in the life sciences industry, where strict regulations and sensitive data present unique challenges. By combining perspectives from business management, industrial microbiology, and AI, the work explores how advanced personalization strategies—powered by algorithms such as collaborative filtering, reinforcement learning, and neural networks—can deliver more targeted, effective, and compliant marketing campaigns. The study discusses practical applications in pharmaceuticals, biotechnology, and food technology, supported by case-based insights. It also highlights how compliance with frameworks like HIPAA and GDPR can shift from being a constraint to a competitive advantage when applied strategically. Beyond the technical aspects, the paper emphasizes the importance of continuous data integration, ethical responsibility, and innovation in AI deployment. The findings suggest that early adopters of AI-driven personalization in life sciences are positioned to enhance engagement, build trust, and achieve sustainable business growth while improving outcomes for both healthcare professionals and patients.</i>

本研究探讨了人工智能（Artificial Intelligence，AI）如何变革生命科学行业的数字营销——该行业因严苛的监管要求与敏感数据属性，面临独特的发展挑战。本研究融合企业管理、工业微生物学与人工智能的研究视角，探讨了以协同过滤、强化学习、神经网络等算法为支撑的高级个性化策略，如何助力打造更具精准性、实效性与合规性的营销活动。本研究还探讨了该技术在制药、生物技术与食品科技领域的实际应用，并辅以基于案例的研究洞察作为支撑。同时，本研究指出，若从战略层面落地合规要求，那么遵循《健康保险流通与责任法案（Health Insurance Portability and Accountability Act，HIPAA）》与《通用数据保护条例（General Data Protection Regulation，GDPR）》的合规框架，可将合规约束转化为竞争优势。除技术维度外，本研究还强调了在人工智能部署过程中，持续的数据整合、伦理责任与技术创新的重要性。研究结果表明，生命科学领域中率先采用人工智能驱动的个性化营销方案的企业，能够在优化医疗专业人员与患者体验的同时，提升用户参与度、建立信任并实现可持续的业务增长。